Potential involvement of the bone marrow in experimental Graves’ disease and thyroid eye disease

Potential involvement of the bone marrow in experimental Graves’ disease and thyroid eye disease

IntroductionGraves’ disease is an autoimmune disorder caused by auto-antibodies against the thyroid stimulating hormone receptor (TSHR). Overstimulation of the TSHR induces hyperthyroidism and thyroid eye disease (TED) as the most common extra thyroidal manifestation of Graves’ disease. In TED, the...

Full description

Bibliographic Details
Main Authors:	Anne Gulbins, Mareike Horstmann, Simone Keitsch, Matthias Soddemann, Barbara Wilker, Gregory C. Wilson, Ryan Zeidan, Gary D. Hammer, Anke Daser, Nikolaos E. Bechrakis, Gina-Eva Görtz, Anja Eckstein
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Endocrinology
Subjects:	bone marrow linsitinib autoimmunity inflammation small molecule IGF-1R antagonist GD: Graves’ disease thyroid eye disease (TED)
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2023.1252727/full

Similar Items

Significance of thyroperoxidase and thyroglobulin antibodies in medically treated Graves’ disease
by: Stefan Matei Constantinescu, et al.
Published: (2023-12-01)

Emerging therapies in the medical management of thyroid eye disease
by: Alisha Kamboj, et al.
Published: (2023-12-01)

Systematic review of ocular surface treatments in the setting of thyroid eye disease
by: Anthony Stephen Wong, et al.
Published: (2024-06-01)

Effects of linsitinib on M22 and IGF:1-treated 3D spheroids of human orbital fibroblasts
by: Fumihito Hikage, et al.
Published: (2025-01-01)

The association of race with thyroid eye disease presentation and outcomes
by: Diane Wang, et al.
Published: (2024-01-01)

Psychiatric complications in Graves’ disease
by: Mats Holmberg, et al.
Published: (2024-02-01)

Utility of colour flow doppler ultrasonography to differentiate gestational transient thyrotoxicosis and graves disease in pregnancy
by: Vijay Sheker Reddy Danda, et al.
Published: (2024-01-01)

Targeted immunotherapies for Graves’ thyroidal & orbital diseases
by: Alan Chun Hong Lee, et al.
Published: (2025-03-01)

Smoking enhances proliferation, inflammatory markers, and immunoglobulins in peripheral blood mononuclear cells from Graves’ patients
by: Bushra Shahida, et al.
Published: (2024-05-01)

Commentary: Azathioprine as an adjuvant therapy in severe Graves’ disease: a randomized controlled open-label clinical trial
by: Madhukar Mittal, et al.
Published: (2024-02-01)

Selenium and Graves’ Disease
by: Vahab Fatourechi, et al.
Published: (2024-10-01)

Predicting remission of Graves' disease following treatment with antithyroid drugs
by: Natalya V. Drogashevskaya, et al.
Published: (2023-04-01)

Personalised immunomodulating treatments for Graves’ disease: fact or fiction?
by: Tristan Struja, et al.
Published: (2017-08-01)

Dermopathy, Acropachy and Orbitopathy in Graves’ Disease
by: James Young, et al.
Published: (2024-08-01)

Graves’ Eye Disease: Clinical and Radiological Diagnosis
by: Kasen R. Hutchings, et al.
Published: (2023-01-01)

Graves' ophthalmopathy
by: Swiss Medical Weekly
Published: (2002-01-01)

Steroid Treatment Focused Management of Graves’ Ophthalmopathy
by: Condeng Y. H., et al.
Published: (2024-09-01)

Platelet indices in graves disease, especially plateletcrit
by: Saliha Yildiz, et al.
Published: (2020-06-01)

Review of Current First-Line Pharmacotherapy Strategies for Thyroid Eye Disease
by: Julia Ryniecka, et al.
Published: (2025-01-01)

Cross-sectional study of thyroid associated orbitopathy in a South African thyroid clinic
by: Sandra De Vasconcelos, et al.
Published: (2025-02-01)

On selenium deficiency in Graves’ disease patients with autoimmune ophthalmopathy
by: Yu.V. Buldygina, et al.
Published: (2019-04-01)

Updates in the Management of Graves Disease in Children
by: Yun Jeong Lee
Published: (2023-12-01)

Osteogenesis imperfecta in combination with Graves disease
by: Marina S. Sheremeta, et al.
Published: (2017-12-01)

Myopathy Associated with Treatment of Graves’ Disease
by: Yoon-Kyung Ji, et al.
Published: (2021-09-01)

Preoperative preparation for Graves’ disease
by: Tianfeng Xu, et al.
Published: (2023-08-01)

The role of Lymphocytes Apoptosis in Grave's Disease Patients
by: Israa F. J. Al-Samaraee, et al.
Published: (2011-01-01)

Incidence and risk factors for Graves’ orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves’ disease: investigation of 1,553 cases with newly diagnosed Graves’ disease and proposal of a predictive score
by: Natsuko Watanabe, et al.
Published: (2023-11-01)

Significance of HLA in Graves’ disease and Graves’ orbitopathy in Asian and Caucasian populations – a systematic review
by: Magdalena Stasiak, et al.
Published: (2023-09-01)

Graves disease is associated with increased risk of clinical Alzheimer’s disease: evidence from the Medicare system
by: Arseniy Pavlovich Yashkin, et al.
Published: (2024-02-01)

Graves' disease with pancytopenia: A rare case report
by: Neda Meftah, et al.
Published: (2024-01-01)

Fetal Hyperthyroidism Secondary to Maternal Basedow–Graves' Disease
by: Julio Soto, et al.
Published: (2024-04-01)

Asssociation of vitamin D with autoimmune ophthalmopathy in Graves’ disease
by: Yu.V. Buldygina, et al.
Published: (2020-01-01)

Ocular surface disease index in Graves’ orbitopathy: a cross-sectional study
by: Maria Novella Maglionico, et al.
Published: (2024-12-01)

Graves' ophtalmopathy: natural history and treatment outcomes
by: D Noth, et al.
Published: (2001-10-01)

Autoimmune Thyroiditis Shifting from Hashimoto’s Thyroiditis to Graves’ Disease
by: Narantsatsral Daramjav, et al.
Published: (2023-04-01)

Graves-Basedow disease and potential risk factors
by: Živanović Dušica, et al.
Published: (2008-01-01)

Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves’ disease
by: Nami Suzuki, et al.
Published: (2025-01-01)

Encephalopathy associated with autoimmune thyroid disease: A grave situation
by: Charul R Mehta, et al.
Published: (2023-01-01)

Thyroid hemiagenesis with Graves’ disease: The first reported case in Lebanon
by: Mohamad Fleifel, et al.
Published: (2023-12-01)

Vitamin D Levels in Patients with Active and Remission Graves’ Disease
by: Natapon Rattanamusik, et al.
Published: (2023-07-01)